Provided by Tiger Trade Technology Pte. Ltd.

Evotec SE

1.88
-0.0300-1.57%
Pre-market: 1.86-0.0200-1.06%08:16 EDT
Volume:65.94K
Turnover:123.74K
Market Cap:668.40M
PE:-2.96
High:1.89
Open:1.88
Low:1.86
Close:1.91
52wk High:4.27
52wk Low:1.86
Shares:355.53M
Float Shares:271.00M
Volume Ratio:2.38
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6341
EPS(LYR):-0.3422
ROE:-26.08%
ROA:-5.39%
PB:0.87
PE(LYR):-5.49

Loading ...

Press Release: Ad Hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-year 2026 Outlook

Dow Jones
·
Jul 14

Diamond Electric Expands Share Base as EVO FUND Exercises 8th Series Rights

TIPRANKS
·
Jul 01

Evotec SE Reports Goldman Sachs’ Voting Rights Stake Rising to 14.62%

TIPRANKS
·
Jul 01

Evotec Expands Prefabricated Drug Manufacturing Offerings

MT Newswires Live
·
Jun 30

Evotec SE Discloses June 15 Share Sale by Management Board Member

TIPRANKS
·
Jun 17

Evolution Begins Share Buyback to Optimize Capital Structure

TIPRANKS
·
May 25

Evolution launches EUR 2 billion buyback and secures new credit line

TIPRANKS
·
May 19

STAAR Surgical (STAA) Is Up 15.2% After EVO+ China Surge Drives Sharp Q1 Profit Rebound – Has The Bull Case Changed?

Simply Wall St.
·
May 18

Evolution Gaming Group AB (EVO) Gets a Buy from Exane BNP Paribas

TIPRANKS
·
May 15

Embark Early Education Wins Strong Shareholder Backing at AGM

TIPRANKS
·
May 11

Embark Early Education Opens Twelfth AGM with Governance-Focused Agenda

TIPRANKS
·
May 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 08

H.C. Wainwright Reaffirms Their Buy Rating on Evotec AG (EVO)

TIPRANKS
·
May 07

TD Cowen Remains a Buy on Evotec AG (EVO)

TIPRANKS
·
May 07

Evotec SE Posts Weak Q1 2026 but Doubles Down on ‘Horizon’ Transformation and Mid-Term Growth Targets

TIPRANKS
·
May 06

Evotec SE reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

Evotec Q1 EPS $(0.40) Misses $0.08 Estimate, Sales $183.430M Miss $197.190M Estimate

Benzinga Earnings
·
May 06

Evotec nominates first preclinical development candidate from Almirall pact

TIPRANKS
·
May 04

Evotec, Almirall Nominate First Preclinical Development Candidate in Dermatology Partnership; Shares Up Pre-Bell

MT Newswires Live
·
May 04

Evotec Secures Grants for Tuberculosis Drug Development

MT Newswires Live
·
Apr 30